Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM DISHMAN PHARMA NGL FINE CHM/
DISHMAN PHARMA
 
P/E (TTM) x 33.7 30.0 112.3% View Chart
P/BV x 5.8 3.3 173.3% View Chart
Dividend Yield % 0.1 0.7 12.6%  

Financials

 NGL FINE CHM   DISHMAN PHARMA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
DISHMAN PHARMA
Mar-16
NGL FINE CHM/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,569374 686.2%   
Low Rs1,161129 901.0%   
Sales per share (Unadj.) Rs450.0197.0 228.4%  
Earnings per share (Unadj.) Rs33.221.2 156.5%  
Cash flow per share (Unadj.) Rs51.434.7 148.2%  
Dividends per share (Unadj.) Rs1.752.00 87.5%  
Avg Dividend yield %0.10.8 11.8%  
Book value per share (Unadj.) Rs360.1179.9 200.2%  
Shares outstanding (eoy) m6.1880.70 7.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.11.3 324.4%   
Avg P/E ratio x56.211.9 473.4%  
P/CF ratio (eoy) x36.37.3 499.9%  
Price / Book Value ratio x5.21.4 370.1%  
Dividend payout %5.39.4 55.9%   
Avg Mkt Cap Rs m11,52320,307 56.7%   
No. of employees `000NANA-   
Total wages/salary Rs m3695,355 6.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,78115,898 17.5%  
Other income Rs m55265 20.8%   
Total revenues Rs m2,83616,163 17.5%   
Gross profit Rs m3504,103 8.5%  
Depreciation Rs m1131,091 10.4%   
Interest Rs m18944 1.9%   
Profit before tax Rs m2742,334 11.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m69624 11.0%   
Profit after tax Rs m2051,710 12.0%  
Gross profit margin %12.625.8 48.7%  
Effective tax rate %25.126.7 93.9%   
Net profit margin %7.410.8 68.5%  
BALANCE SHEET DATA
Current assets Rs m1,62711,018 14.8%   
Current liabilities Rs m5839,517 6.1%   
Net working cap to sales %37.59.4 397.5%  
Current ratio x2.81.2 241.0%  
Inventory Days Days6557 114.3%  
Debtors Days Days8653 24,721.5%  
Net fixed assets Rs m1,24418,787 6.6%   
Share capital Rs m31161 19.1%   
"Free" reserves Rs m2,19514,354 15.3%   
Net worth Rs m2,22514,516 15.3%   
Long term debt Rs m214,189 0.5%   
Total assets Rs m2,87129,805 9.6%  
Interest coverage x15.93.5 458.6%   
Debt to equity ratio x00.3 3.2%  
Sales to assets ratio x1.00.5 181.6%   
Return on assets %7.88.9 87.3%  
Return on equity %9.211.8 78.2%  
Return on capital %13.017.5 74.2%  
Exports to sales %74.324.9 298.5%   
Imports to sales %9.93.7 265.7%   
Exports (fob) Rs m2,0663,956 52.2%   
Imports (cif) Rs m276594 46.5%   
Fx inflow Rs m2,0954,952 42.3%   
Fx outflow Rs m304697 43.7%   
Net fx Rs m1,7904,255 42.1%   
CASH FLOW
From Operations Rs m3532,786 12.7%  
From Investments Rs m-270-1,529 17.7%  
From Financial Activity Rs m-11-941 1.1%  
Net Cashflow Rs m72317 22.7%  

Share Holding

Indian Promoters % 73.1 61.4 119.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 23.0 0.2%  
FIIs % 0.0 12.0 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.9 38.6 69.8%  
Shareholders   16,410 52,291 31.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs Dishman Pharma Share Price Performance

Period NGL FINE CHM Dishman Pharma S&P BSE HEALTHCARE
1-Day -0.58% 2.87% 1.18%
1-Month 2.94% -2.45% -0.75%
1-Year 77.47% 96.38% 61.82%
3-Year CAGR 9.82% 89.34% 18.16%
5-Year CAGR 35.36% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 73.1% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 5.3%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.